View |
DR-XY37110_PI_01.pdf
|
DR-XY37110
|
Salbutamol + Guaifenesin
|
Intasma
|
1 mg/50 mg per 5 mL
|
Syrup (Orange Flavor)
|
-
|
Sydenham Laboratories, Inc.
|
Philippines
|
-
|
15 April 2020
|
01 December 2024
|
View |
|
DR-XY37122
|
Montelukast (As Sodium)
|
Airmaxx
|
4 mg
|
Chewable Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
16 September 2019
|
02 December 2024
|
View |
|
DR-XY37123
|
Oxymetazoline Hydrochloride
|
Nasofree
|
0.05%
|
Nasal Solution (Spray)
|
Decongestant
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
16 August 2024
|
04 December 2029
|
View |
|
DR-XY37124
|
Atosiban (as acetate)
|
Tractocile
|
7.5mg/Ml (6.75mg/0.9mL per Vial)
|
Solution for Injection
|
Other Gynecological
|
Ferring GmbH
|
Germany
|
Renewal
|
31 October 2023
|
02 December 2028
|
View |
|
DR-XY37125
|
Atosiban (as acetate)
|
Tractocile
|
7.5mg/Ml (37.5mg/5mL per vial)
|
Concentrate Solution for I.V. Infusion
|
-
|
Ferring GmbH
|
Germany
|
-
|
24 October 2022
|
02 December 2028
|
View |
|
DR-XY37130
|
Pioglitazone (as hydrochloride)
|
GLITAZ
|
15 mg
|
Tablet
|
Oral Hypoglycemic Agent
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
13 June 2024
|
01 December 2029
|
View |
|
DR-XY37136
|
Co-Amoxiclav
|
Soonmelt
|
500mg/125mg
|
Film Coated Tablet
|
-
|
yung shin pharmaceutial ind. Co., ltd.
|
taiwan
|
-
|
26 December 2019
|
02 December 2024
|
View |
|
DR-XY37140
|
Paracetamol
|
Tempra Forte
|
500 mg
|
Tablet
|
-
|
P.T. Taisho Pharmaceutical Indonesia Tbk.
|
Indonesia
|
-
|
12 December 2019
|
04 December 2024
|
View |
|
DR-XY37148
|
Cefuroxime (as axetil)
|
Furcef
|
250mg /5mL
|
Granules for Suspension
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
02 January 2020
|
03 December 2024
|
View |
|
DR-XY37151
|
Olmesartan Medoxomil + Hydrochlorothiazide
|
Alzor HCT
|
40mg/12.5mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker / Diuretic
|
Ajanta Pharma Limited
|
India
|
Initial
|
30 March 2022
|
03 December 2024
|
View |
|
DR-XY37155
|
Glimepiride
|
Perglim 2
|
2 mg
|
Tablet
|
Oral Hypoglycemic Agent
|
Inventia Healthcare Limited
|
India
|
Renewal
|
11 July 2024
|
03 December 2029
|
View |
|
DR-XY37158
|
Lidocaine Hydrochloride (as monohydrate)
|
Eurocaine
|
20mg/Ml (2%w/v)
|
Solution For Injection (IV)
|
Local Anesthetic
|
Euro-med Laboratories Phil. Inc.
|
Philippines
|
Renewal
|
04 August 2024
|
03 December 2029
|
View |
|
DR-XY37159
|
Olmesartan medoxomil + Hydrochlorothiazide
|
Alzor HCT
|
20 mg/12.5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker / Diuretic
|
Ajanta Pharma Limited
|
India
|
Initial
|
30 March 2022
|
03 December 2024
|
View |
|
DR-XY37168
|
Metronidazole
|
Medrazole
|
500mg
|
Tablet
|
-
|
Sydenham Laboratories, Inc.
|
Philippines
|
-
|
09 March 2021
|
07 December 2024
|
View |
|
DR-XY37169
|
Betahistine hydrochloride
|
OVERT
|
8mg
|
Tablet
|
Anti-vertigo
|
E.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
27 May 2024
|
04 December 2029
|
View |
|
DR-XY37173
|
Lisinopril
|
Lisnoxl
|
5 mg
|
Tablet
|
Angiotensin Converting Enzyme (ACE) Inhibitor
|
XL Laboratories Pvt Ltd
|
India
|
Renewal
|
14 February 2024
|
04 December 2029
|
View |
|
DR-XY37174
|
Potassium Citrate (As Monohydrate)
|
Tascit
|
1080 mg (10 mEq)
|
Extended-Release Tablet
|
-
|
Amherst Laboratories, Inc.
|
philipines
|
-
|
21 February 2020
|
08 December 2024
|
View |
|
DR-XY37175
|
Betahistine hydrochloride
|
OVERT
|
16 mg
|
Tablet
|
Antivertigo
|
E.L. Laboratories, Inc.
|
Philippines
|
Renewal
|
19 May 2024
|
04 December 2029
|
View |
|
DR-XY37180
|
Mannitol
|
None
|
200mg/Ml (20%w/v)
|
Solution for I.V. Infusion
|
Diuretic
|
Amanta Healthcare Ltd.
|
India
|
Renewal
|
01 July 2024
|
04 December 2029
|
View |
|
DR-XY37181
|
Tramadol Hydrochloride/Paracetamol
|
Dolcet Mini
|
18.75/162.50mg
|
Tablet
|
-
|
Janssen Korea Ltd.
|
Korea
|
-
|
19 December 2019
|
22 December 2024
|